EGRP News Flash - April 3, 2008
Policy of the National Cancer Institute for Allowable Requested Budget Levels of Competing Continuation (Type 2) R01, U01 and P01 Applications
The Epidemiology and Genetics Research Program (EGRP) reminds current and prospective grantees that NCI restricts all competing continuation (Type 2) R01, U01 and P01 applications to a 20% increase over the last funding period. In cases where the last non-competing year may be substantially lower than previous years, applicants may cite the average yearly direct cost for the previous funding period as the base for the policy cap on the Type 2 applications. Type 2 applications that are within the pay line or selected for funding by exception that do not conform to the cap will be subject to a reduction in the total budget to align it with the NCI Type 2 policy, in addition to the current NCI programmatic reductions and applicable Study Section/Integrative Review Group recommended reductions.
Answers to frequently asked questions are available for R01s and U01s. For questions about P01s, contact an EGRP Program Director.
Access the NIH Guide for Grants and Contracts for details:
- NOT-CA-01-016 (for R01s and U01s), and
- NOT-CA-00-010 (for P01s)
Subscribe to EGRP Bulletins and News Flashes
You are welcome to invite others to subscribe to receive occasional Bulletins and News Flashes from the Epidemiology and Genetics Research Program (EGRP).
- To subscribe to FRIENDS-OF-NCI-EGRP-L, contact lynchs@mail.nih.gov.
